metricas
covid
Buscar en
Revista Española de Cirugía Ortopédica y Traumatología (English Edition)
Toda la web
Inicio Revista Española de Cirugía Ortopédica y Traumatología (English Edition) Bloodless surgery total kree arthroplasty
Journal Information
Vol. 52. Issue 6.
Pages 372-380 (November - December 2008)
Share
Share
Download PDF
More article options
Vol. 52. Issue 6.
Pages 372-380 (November - December 2008)
Original paper
Full text access
Bloodless surgery total kree arthroplasty
Cirugía sin sangre en las prótesis totales de rodilla
Visits
1199
E. Moreno Zurriaríana,
Corresponding author
gepecelm@sc.ehu.es

Corresponding author: Universidad del País Vasco. Paseo Dr. Begiristain, 105. 20014 San Sebastián. España.
, M. Echenique Elizondob, J.I. Emparanza Knorrc, J. Usabiaga Zarranza
a Department of Trauma and Orthopedic Surgery. Donosita Hospital. San Sebastián. Spain
b Department of Surgery. University of the Basque Country. San Sebastián. Spain
c Research Unit. Donosita Hospital. San Sebastián. Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Introduction

The purpose of this study is to try to decrease the amounts of blood transfused in knee prosthetic surgery by using blood-saving methods. We consider that a realistic target would be reducing the transfusion rate to less than 10%.

Materials and methods

Cohort study made up of a current cohort of 105 patients (107 total knee arthroplasties) and a historical control cohort of 193 patients (197 total knee arthroplasties). The study period extended from May 2004 to August 2005.

Results

Transfusion rate: historical cohort: 57.3% (113 patients); current cohort: 7.5% (8 patients). Erythropoietin has led to an increase in preoperative hemoglobin levels (mean value: 2.3 g/dl higher than the initial level). In the historical cohort, 3 patients entered a predonation program. In the current group, 34/55 patients (61.8%) entered such a program. The mean preoperative hemoglobin level was 13.9 g/dl (range: 13-14.9 g/dl) and decreased to 12 (range: 10.6-13.6 g/dl) after extraction of the two blood units. Of the 67 blood bags extracted, only 45 (67.1%) were used and 22 were discarded (32.9%).

Conclusions

Erythropoietin and the autotransfusion program have shown their usefulness in reducing the amount of blood transfused in prosthetic knee surgery.

Key words:
total knee replacement
bloodless surgery
Introducción

El objetivo del trabajo es intentar disminuir el índice transfusional en cirugía de prótesis de rodilla aplicando métodos de ahorro de sangre. Consideramos un objetivo realista conseguir un índice transfusional por debajo del 10%.

Material y método

Estudio de cohortes: una cohorte actual, con 105 pacientes (107 prótesis totales de rodilla), y otra histórica de control con 193 (197 prótesis totales de rodilla). El período de estudio comprende desde mayo de 2004 hasta agosto de 2005.

Resultados

El índice transfusional en la cohorte histórica fue del 57,3% (113 pacientes), y en la cohorte actual del 7,5% (8 pacientes). La eritropoyetina ha conseguido una mejoría en el aumento de los niveles de hemoglobina preoperatorios: valor promedio de 2,3 g/dl más alto que el nivel inicial. En la cohorte histórica, 3 pacientes entraron en un programa de predonación; en el grupo actual, 34/55 pacientes (61,8%). El promedio del nivel de hemoglobina preoperatoria fue de 13,9 g/dl (rango: 13-14,9 g/dl) y pasó a 12 (rango: 10,6-13,6 g/dl) tras la extracción de las dos unidades de sangre. De las 67 bolsas de sangre extraídas, sólo han sido utilizadas 45 (67,1%) y 22 se han desechado (32,9%).

Conclusiones

El empleo de eritropoyetina y el programa de autotransfusión han demostrado su utilidad en el ahorro de sangre a transfundir en la cirugía de prótesis total de rodilla.

Palabras clave:
prótesis total de rodilla
cirugía sin sangre
Full text is only aviable in PDF
References
[1.]
D.A. Ott, D.A. Cooley.
Cardiovascular surgery in Jehovah's Witnesses.
JAMA, 238 (1977), pp. 1256-1258
[2.]
N. Blumberg, J.M. Heal.
Immunomodulation by blood transfusion: an evolving scientific and clinical challenge.
Am J Med, 101 (1996), pp. 299-308
[3.]
E.M. Keating, J.B. Meding, P.M. Faris, M.A. Ritter.
Prediction of transfusion risk in elective knee surgery.
Clin Orthop, 357 (1998), pp. 50-59
[4.]
J.A. Salido, L.A. Marín, L.A. Gómez, P. Zorrilla, C. Martínez.
Preoperative haemoglobin levels and the need for transfusion after prosthetic hip and knee surgery.
J Bone Joint Surg Am, 84 (2002), pp. 216-220
[5.]
S.J.H. Kendall, J. Weir, R. Aspinall, D. Henderson, J. Rosson.
Erythrocyte transfusion causes immunosuppression after total hip replacement.
Clin Orthop, 381 (2000), pp. 145-155
[6.]
P. Innerhofer, A. Klinger, C. Klimmer, D. Fries, W. Nussbaumer.
Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopaedic patients undergoing primary arthroplasty.
Transfusion, 45 (2005), pp. 103-110
[7.]
B. Bierbaum, J.J. Callaghan, J.O. Galante, H.E. Rubash, R.E. Tooms, R.B. Welch.
An analysis of blood management in patients having a total hip or knee arthroplasty.
J Bone Joint Surg Am, 81 (1999), pp. 2-10
[8.]
R. Slappendel, R. Dirksen, E.W.G. Weber, D.B. Van der Schaal.
An algorithm to reduce allogeneic red blood cell transfusions for major orthopaedic surgery.
Acta Orthop Scand, 74 (2003), pp. 569-575
[9.]
F.D. Rubens, M. Boodhwani, G. Lavalee, T. Mesana.
Perioperative red blood cell salvage.
Can J Anaesth, 50 (2003), pp. 31-40
[10.]
M.F. Murphy, T.B. Wallington, P. Kelsey, F. Boulton, M. Bruce, H. Cohen, et al.
British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions.
Br J Haematol, 113 (2001), pp. 24-31
[11.]
J.L. Carson.
The limits of bloodless surgery.
TATM, 6 (2005), pp. 52-55
[12.]
A.S. Keats.
The ASA. Classification of phisical status. A recapitulation.
Anaesthesiology, 49 (1978), pp. 233-236
[13.]
M. Amin, D. Fergusson, A. Aziz, K. Wilson, D. Coyle, P. Hébert.
The cost of allogeneic red blood cells —a systematic review.
Transfus Med, 13 (2003), pp. 275-285
[14.]
M. Amin, D. Fergusson, W. Kumanan, A. Tinmouth, A. Aziz, D. Coyle, et al.
The societal cost of allogeneic red blood cells and red blood cell transfusion in Canada.
Transfusion, 44 (2004), pp. 1479-1486
[15.]
E. Bisbe, N. Sáez, N. Nomen, J. Castillo, X. Santiveri, C. Mestre, et al.
Eritropoyetina, sola o como coadyuvante del programa de donación de sangre autóloga en cirugía ortopédica mayor.
Rev Esp Anestesiol Reanim, 50 (2003), pp. 395-400
[16.]
C. Couvret, S. Tricoche, A. Baud, B. Dabo, S. Buchet, M. Palud, et al.
The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty. The effect on subsequent rates.
Anaesth Analg, 94 (2002), pp. 815-823
[17.]
N. Rosencher, H.E. Kerkkamp, G. Macheras, L.M. Munuera, G. Menichella, D.M. Barton, OSTHEO Investigation, et al.
Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe.
Transfusion, 43 (2003), pp. 459-469
[18.]
D.A. Henry, P.A. Charles, A.J. Moxey, D. O’Connell, M.A. Forgie, P.S. Wells, et al.
The Cochrane Library, (2004),
[19.]
H. Bae, G.H. Westric, T.P. Sculco, E.A. Salvati, L.M. Reich.
The effect or preoperative donation of autologous blood on deepvein thrombosis after total hip arthroplasty.
J Bone Joint Surg Br, 83 (2001), pp. 676-679
[20.]
M. Sáez Bruguera.
Donación autóloga preoperatoria: tipos, indicaciones y organización.
Actualización en medicina transfusional perioperatoria, Universidad de Málaga, (2004),
[21.]
C.E. Van Iperen, R.J. Kraaijenhagen, D.H. Biesma, Y. Beguin, J.J.M. Marx, A. Van de Wiel.
Iron metabolism and erythropoiesis after surgery.
[22.]
J. Cuenca, J.A. García Erce, A.A. Martínez, V.M. Solano, J. Molina, M. Muñoz.
Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data.
Arch Orthop Trauma Surg, 125 (2005), pp. 342-347
[23.]
G.F. Chimento, V. Pavone, N. Sharrock, B. Kahn, J. Cahill, T.P. Sculco.
Minimally invasive total hip arthroplasty: a prospective randomised study.
J Arthroplasty, 20 (2005), pp. 139-144
[24.]
R.S. Laskin, B. Beksac, A. Phongjunakorn, K. Pittors, J. Davis, J.C. Shim, et al.
Minimally invasive total knee replacement through a mini-midvastus incision: an outcome study.
Clin Orthop, 428 (2003), pp. 74-81
[25.]
R.O. Niskanen, O.L. Korkala, J. Haapala, H.O. Kuokkanen, J.P. Kaukonen, S.A. Salo.
Drainage is of no use in primary uncomplicated cemented hip and knee arthroplasty for osteoarthritis.
J Arthroplasty, 15 (2000), pp. 567-569
[26.]
M.J. Parker, C.P. Roberts, D. Hay.
Closed suction drainage for hip and knee arthroplasty. A meta-analysis.
J Bone Joint Surg Am, 86 (2004), pp. 1146-1152
[27.]
P.A. Carless, D.A. Henry, A.J. Moxey, D.L. O’Connell, D.A. Fergusson.
The Cochrane Library, (2004),
[28.]
F.J. Manso Marín, M. Galindo Palazuelos, M. Peraza Sánchez, I. González Fernández, F. Ramos Goicoechea, A. Castro Ugalde.
Autotransfusión postoperatoria en la cirugía protésica primaria de rodilla.
Rev Esp Anestesiol, 51 (2004), pp. 316-321
[29.]
Consensus conference.
Perioperative red blood cell transfusion.
JAMA, 260 (1998), pp. 2700-2703
Copyright © 2008. Sociedad Española de Cirugía Ortopédica y Traumatología (SECOT). All rights reserved
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos